Shinichi Ikuta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shinichi Ikuta has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
Naoki Yamanaka
37 shared publicationsTsukasa Aihara
34 shared publicationsTakayoshi Nakajima
17 shared publicationsHidenori Yanagi
Department of Digestive Surgery, Meiwa Hospital
10 shared publicationsAyako Kakuno
Department of Pathology, Meiwa Hospital
8 shared publicationsHiroya Iida
6 shared publications
Latest Publications
- 6 November 2026
- Published by Elsevier in Surgical Oncology
- Vol. 70
Prognostic heterogeneity and risk stratification in surgically treated borderline resectable 2 hepatocellular carcinoma
- 6 November 2026
- Published by Elsevier in Surgical Oncology
- Vol. 70
Prognostic heterogeneity and risk stratification in surgically treated borderline resectable 2 hepatocellular carcinoma
- Open Access
Outcomes of Combined Hepatectomy and Intraoperative Ablation for Multiple Colorectal Liver Metastases: A Single-Center Retrospective Study
Introduction: Radical hepatectomy is the standard curative treatment for colorectal liver metastases (CRLMs). However, extensive resection may be contraindicated in patients with insufficient liver reserve or anatomically complex disease. Although ablation therapy is generally not recommended as a primary curative modality in current guidelines, intraoperative ablation may facilitate parenchymal-sparing, curative-intent treatment in selected high-risk patients. Methods: This retrospective cohort study included 118 patients who underwent curative-intent hepatectomy for multiple CRLM. Patients were categorized into hepatectomy-only (Hx) and hepatectomy plus intraoperative ablation (Hx + Abl) groups, and propensity score matching (PSM) generated 29 balanced pairs. Overall survival (OS) and hepatic progression-free survival (HPFS) were compared using a log-rank test. Cox regression identified predictors of OS, and receiver operating characteristic (ROC) analysis evaluated tumor size associated with local recurrence after ablation. Results: Before PSM, the HX + Abl group showed higher tumor burden and Beppu scores, and demonstrated inferior OS and HPFS. After PSM, oncological outcomes were comparable. Perioperative outcomes, including major complications and post-hepatectomy liver failure (PHLF), were similar. Preoperative chemotherapy was an independent predictor of OS. Among 99 ablated tumors, local recurrence occurred in 12 lesions, and ROC analysis identified tumor size ≤ 15mm as the optimal cutoff predicting local recurrence. Conclusions: In selected high-risk CRLM patients, hepatectomy with intraoperative ablation had no statistically significant difference in OS and HPFS compared with hepatectomy alone without increasing major complications or PHLF.
Open AccessOutcomes of Combined Hepatectomy and Intraoperative Ablation for Multiple Colorectal Liver Metastases: A Single-Center Retrospective Study
Introduction: Radical hepatectomy is the standard curative treatment for colorectal liver metastases (CRLMs). However, extensive resection may be contraindicated in patients with insufficient liver reserve or anatomically complex disease. Although ablation therapy is generally not recommended as a primary curative modality in current guidelines, intraoperative ablation may facilitate parenchymal-sparing, curative-intent treatment in selected high-risk patients. Methods: This retrospective cohort study included 118 patients who underwent curative-intent hepatectomy for multiple CRLM. Patients were categorized into hepatectomy-only (Hx) and hepatectomy plus intraoperative ablation (Hx + Abl) groups, and propensity score matching (PSM) generated 29 balanced pairs. Overall survival (OS) and hepatic progression-free survival (HPFS) were compared using a log-rank test. Cox regression identified predictors of OS, and receiver operating characteristic (ROC) analysis evaluated tumor size associated with local recurrence after ablation. Results: Before PSM, the HX + Abl group showed higher tumor burden and Beppu scores, and demonstrated inferior OS and HPFS. After PSM, oncological outcomes were comparable. Perioperative outcomes, including major complications and post-hepatectomy liver failure (PHLF), were similar. Preoperative chemotherapy was an independent predictor of OS. Among 99 ablated tumors, local recurrence occurred in 12 lesions, and ROC analysis identified tumor size ≤ 15mm as the optimal cutoff predicting local recurrence. Conclusions: In selected high-risk CRLM patients, hepatectomy with intraoperative ablation had no statistically significant difference in OS and HPFS compared with hepatectomy alone without increasing major complications or PHLF.
- Open Access
- 3 January 2026
- Published by International Institute of Anticancer Research in Cancer Diagnosis & Prognosis
- Vol. 6 (1) , 40-51
C-reactive Protein-to-Albumin Ratio as a Superior Inflammatory Marker in Resected Biliary Tract Cancer: Development of a Prognostic Nomogram Complementary to TNM Stagin
Background/Aim: Consensus on the most informative inflammatory marker for prognosis in biliary tract cancer (BTC) is lacking. The aim of this study was to comprehensively evaluate preoperative inflammatory indices and develop a prognostic nomogram complementary to TNM staging. Patients and Methods: A total of 247 patients with resected BTC were retrospectively analyzed. Eight inflammatory indices, including prognostic nutritional index (PNI) and C-reactive protein-to-albumin ratio (CAR), were assessed alongside non-TNM clinicopathological variables. Least absolute shrinkage and selection operator (LASSO) regression identified overall survival-associated variables for multivariable Cox regression and nomogram construction. Model performance was evaluated using Kaplan-Meier analysis, concordance (C-) index, time-dependent area under the curve (tdAUC), decision curve analysis (DCA), and calibration plots, with bootstrap validation. Results: LASSO selected PNI and CAR; CAR remained independently significant. The nomogram incorporated CAR and five clinicopathological factors: body mass index ≥25 kg/m2, carbohydrate antigen 19-9 >37 U/ml, moderate/poor differentiation, perineural invasion, and residual tumor status. Patients were stratified by nomogram score into four risk groups showing distinct survival differences. Notably, 50.6% of TNM Stage I-II were reclassified as higher risk, 16.1% of Stage III-IV as lower risk. The nomogram achieved C-index 0.722 versus 0.659 for TNM (p=0.022), with superior tdAUCs, clinical benefit on DCA, and good calibration. Consistent prognostic performance was observed across BTC subtypes and TNM stages. Conclusion: CAR demonstrated superiority over other inflammatory indices in resected BTC. This CAR-based nomogram complements TNM staging, offering enhanced prognostic stratification for patients with heterogeneous outcomes within the same anatomical stage.
- 3 January 2026
- Published by International Institute of Anticancer Research in Cancer Diagnosis & Prognosis
- Vol. 6 (1) , 40-51
Open AccessC-reactive Protein-to-Albumin Ratio as a Superior Inflammatory Marker in Resected Biliary Tract Cancer: Development of a Prognostic Nomogram Complementary to TNM Stagin
Background/Aim: Consensus on the most informative inflammatory marker for prognosis in biliary tract cancer (BTC) is lacking. The aim of this study was to comprehensively evaluate preoperative inflammatory indices and develop a prognostic nomogram complementary to TNM staging. Patients and Methods: A total of 247 patients with resected BTC were retrospectively analyzed. Eight inflammatory indices, including prognostic nutritional index (PNI) and C-reactive protein-to-albumin ratio (CAR), were assessed alongside non-TNM clinicopathological variables. Least absolute shrinkage and selection operator (LASSO) regression identified overall survival-associated variables for multivariable Cox regression and nomogram construction. Model performance was evaluated using Kaplan-Meier analysis, concordance (C-) index, time-dependent area under the curve (tdAUC), decision curve analysis (DCA), and calibration plots, with bootstrap validation. Results: LASSO selected PNI and CAR; CAR remained independently significant. The nomogram incorporated CAR and five clinicopathological factors: body mass index ≥25 kg/m2, carbohydrate antigen 19-9 >37 U/ml, moderate/poor differentiation, perineural invasion, and residual tumor status. Patients were stratified by nomogram score into four risk groups showing distinct survival differences. Notably, 50.6% of TNM Stage I-II were reclassified as higher risk, 16.1% of Stage III-IV as lower risk. The nomogram achieved C-index 0.722 versus 0.659 for TNM (p=0.022), with superior tdAUCs, clinical benefit on DCA, and good calibration. Consistent prognostic performance was observed across BTC subtypes and TNM stages. Conclusion: CAR demonstrated superiority over other inflammatory indices in resected BTC. This CAR-based nomogram complements TNM staging, offering enhanced prognostic stratification for patients with heterogeneous outcomes within the same anatomical stage.
- 18 September 2025
- Published by Springer Nature in Updates in Surgery
- Vol. 78 (3) , 1233-1242
Skin-to-portal junction distance as a simple CT-based predictor of pancreatic fistula after pancreaticoduodenectomy: a validated model
Clinically relevant postoperative pancreatic fistula (CR-POPF) remains a significant concern after pancreaticoduodenectomy (PD), increasing morbidity and mortality. This retrospective study evaluated the skin-to-portal junction distance (SJD), a simple CT-based metric, as a predictor of CR-POPF and developed a validated predictive model for risk stratification. The study included 305 patients undergoing open PD, divided into training (n = 214) and validation (n = 91) cohorts. Sex-specific SJD cutoffs were determined using receiver operating characteristic analysis. Logistic regression identified CR-POPF risk factors and built the model, assessed by area under the curve (AUC), calibration plots, and decision curve analysis (DCA). CR-POPF occurred in 23.9% of patients overall, with incidences of 23.4% and 25.3% in the training and validation cohorts, respectively. High SJD (≥ 78 mm for males, ≥ 64 mm for females; odds ratio [OR] 5.140), main pancreatic duct diameter ≤ 3 mm (OR 2.720), non-pancreatic ductal adenocarcinoma (OR 3.820), and soft pancreatic texture (OR 2.660) were independent predictors. The model achieved AUCs of 0.832 in the training cohort and 0.806 in the validation cohort, with good calibration and clinical utility as shown by DCA. These results compared favorably with the Fistula Risk Score (FRS) and alternative-FRS. The high SJD group had a higher incidence of CR-POPF (36.3% vs. 14.1%, p < 0.001), longer operative time (p = 0.004), greater blood loss (p = 0.047), and more major complications of Clavien–Dindo grade ≥ III (p < 0.001). SJD is a simple, objective predictor of CR-POPF. The validated model facilitates perioperative risk stratification; however, external validation is needed.
- 18 September 2025
- Published by Springer Nature in Updates in Surgery
- Vol. 78 (3) , 1233-1242
Skin-to-portal junction distance as a simple CT-based predictor of pancreatic fistula after pancreaticoduodenectomy: a validated model
Clinically relevant postoperative pancreatic fistula (CR-POPF) remains a significant concern after pancreaticoduodenectomy (PD), increasing morbidity and mortality. This retrospective study evaluated the skin-to-portal junction distance (SJD), a simple CT-based metric, as a predictor of CR-POPF and developed a validated predictive model for risk stratification. The study included 305 patients undergoing open PD, divided into training (n = 214) and validation (n = 91) cohorts. Sex-specific SJD cutoffs were determined using receiver operating characteristic analysis. Logistic regression identified CR-POPF risk factors and built the model, assessed by area under the curve (AUC), calibration plots, and decision curve analysis (DCA). CR-POPF occurred in 23.9% of patients overall, with incidences of 23.4% and 25.3% in the training and validation cohorts, respectively. High SJD (≥ 78 mm for males, ≥ 64 mm for females; odds ratio [OR] 5.140), main pancreatic duct diameter ≤ 3 mm (OR 2.720), non-pancreatic ductal adenocarcinoma (OR 3.820), and soft pancreatic texture (OR 2.660) were independent predictors. The model achieved AUCs of 0.832 in the training cohort and 0.806 in the validation cohort, with good calibration and clinical utility as shown by DCA. These results compared favorably with the Fistula Risk Score (FRS) and alternative-FRS. The high SJD group had a higher incidence of CR-POPF (36.3% vs. 14.1%, p < 0.001), longer operative time (p = 0.004), greater blood loss (p = 0.047), and more major complications of Clavien–Dindo grade ≥ III (p < 0.001). SJD is a simple, objective predictor of CR-POPF. The validated model facilitates perioperative risk stratification; however, external validation is needed.
- Open Access
- 1 January 2025
- Published by Termedia Sp. z.o.o. in Contemporary Oncology
- Vol. 29 (1) , 69-76
Alpha-fetoprotein as a prognostic factor in alpha-fetoprotein-negative hepatocellular carcinoma – integration into post-resection prognostic nomograms
Introduction: This study aimed to validate the prognostic value of alpha- fetoprotein (AFP) in AFP-negative hepatocellular carcinoma (HCC) and develop an AFP-integrated nomogram for post-resection recurrence-free survival (RFS) and overall survival (OS). Material and methods: This...
- 1 January 2025
- Published by Termedia Sp. z.o.o. in Contemporary Oncology
- Vol. 29 (1) , 69-76
Open AccessAlpha-fetoprotein as a prognostic factor in alpha-fetoprotein-negative hepatocellular carcinoma – integration into post-resection prognostic nomograms
Introduction: This study aimed to validate the prognostic value of alpha- fetoprotein (AFP) in AFP-negative hepatocellular carcinoma (HCC) and develop an AFP-integrated nomogram for post-resection recurrence-free survival (RFS) and overall survival (OS). Material and methods: This...
- 21 October 2024
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 409 (1) , 1-11
Intraoperatively measured prehepatectomy portal vein pressure as a useful predictor of posthepatectomy liver failure
Background Predicting posthepatectomy liver failure (PHLF) may be a critical requirement for liver disease patients undergoing hepatectomy. This study retrospectively analyzed the impact of the intraoperatively measured portal vein pressure (PVP) prior to hepatectomy on the prediction of PHLF in hepatectomized patients. Methods A total of 334 hepatectomized patients in whom the PVP was intraoperatively measured before resection at our institution were enrolled in the present study. Outcomes were assessed according to the International Study Group of Liver Surgery definition and the severity of PHLF grading. Results Thirty-nine of the 334 patients (11.6%) developed grade B/C PHLF. The following factors were significantly associated with grade B/C PHLF in a univariate analysis: indocyanine green retention rate after 15 min, Child-Pugh score, prehepatectomy PVP, and transfusion (each P < 0.0001). A prehepatectomy PVP value of 19.5 cmH2O was the optimal cutoff value for predicting grade B/C PHLF. In a multivariate analysis, prehepatectomy PVP (≥ 19.5 cmH2O) was selected as the most relevant risk factor for grade B/C PHLF (P = 0.0003, hazard ratio: 5.96, 95% CI: 1.80–19.70). Conclusions Prehepatectomy PVP can serve as a useful predictor of the risk of PHLF in patients who have undergone hepatectomy. The results emphasize the possibility of reducing the planned extent of hepatic resection when the prehepatectomy PVP value measured intraoperatively exceeds 19.5 cmH2O, and the importance of predicting the PVP before the operation.
- 21 October 2024
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 409 (1) , 1-11
Intraoperatively measured prehepatectomy portal vein pressure as a useful predictor of posthepatectomy liver failure
Background Predicting posthepatectomy liver failure (PHLF) may be a critical requirement for liver disease patients undergoing hepatectomy. This study retrospectively analyzed the impact of the intraoperatively measured portal vein pressure (PVP) prior to hepatectomy on the prediction of PHLF in hepatectomized patients. Methods A total of 334 hepatectomized patients in whom the PVP was intraoperatively measured before resection at our institution were enrolled in the present study. Outcomes were assessed according to the International Study Group of Liver Surgery definition and the severity of PHLF grading. Results Thirty-nine of the 334 patients (11.6%) developed grade B/C PHLF. The following factors were significantly associated with grade B/C PHLF in a univariate analysis: indocyanine green retention rate after 15 min, Child-Pugh score, prehepatectomy PVP, and transfusion (each P < 0.0001). A prehepatectomy PVP value of 19.5 cmH2O was the optimal cutoff value for predicting grade B/C PHLF. In a multivariate analysis, prehepatectomy PVP (≥ 19.5 cmH2O) was selected as the most relevant risk factor for grade B/C PHLF (P = 0.0003, hazard ratio: 5.96, 95% CI: 1.80–19.70). Conclusions Prehepatectomy PVP can serve as a useful predictor of the risk of PHLF in patients who have undergone hepatectomy. The results emphasize the possibility of reducing the planned extent of hepatic resection when the prehepatectomy PVP value measured intraoperatively exceeds 19.5 cmH2O, and the importance of predicting the PVP before the operation.
- Open Access
- 12 August 2024
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 28 (4) , 440-450
Construction and validation of a preoperative prognostic model integrating the novel aspartate aminotransferase-albumin score for hepatocellular carcinoma patients undergoing liver resection
Shinichi Ikuta, Tsukasa Aihara, Meidai Kasai, Takayoshi Nakajima, Naoki Yamanaka. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.24-110
- 12 August 2024
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 28 (4) , 440-450
Open AccessConstruction and validation of a preoperative prognostic model integrating the novel aspartate aminotransferase-albumin score for hepatocellular carcinoma patients undergoing liver resection
Shinichi Ikuta, Tsukasa Aihara, Meidai Kasai, Takayoshi Nakajima, Naoki Yamanaka. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.24-110
- 27 April 2024
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 44 (5) , 2133-2140
Long-term Outcomes of Hepatic Resection Combined With Intraoperative AblationVersusHepatic Resection Alone for Multinodular Hepatocellular Carcinoma: Insights from a Single-center Study
Background/Aim: The efficacy of combining hepatic resection (HR) with ablation therapy in treating multinodular hepatocellular carcinoma (mHCC) remains uncertain. This study aimed to compare the long-term survival outcomes of patients with mHCC undergoing HR combined with intraoperative ablation (HRA) versus those undergoing HR alone. Patients and Methods: A retrospective analysis was conducted on 296 patients diagnosed with early-stage [Barcelona Clinic Liver Cancer (BCLC)-A] or intermediate-stage (BCLC-B) mHCC who underwent initial HR. Patients were divided into two groups: those who received HRA (HRA group, n=159) and those who underwent HR alone (HR group, n=137). Propensity score (PS), estimated as the likelihood of undergoing HRA, was applied to adjust for between-group differences in baseline characteristics. Overall survival (OS) and relapse-free survival (RFS) were compared using Cox regression and Kaplan–Meier analyses. Results: There were no significant differences in survival between the HRA and HR groups, with 5-year OS and RFS rates of 47.7% versus 51.9% (p=0.837) and 17.0% versus 25.9% (p=0.094), respectively. After adjusting for PS, the differences remained non-significant (p=0.579 for OS and p=0.410 for RFS). Consistent results were also observed in PS-adjusted subgroup analysis stratified by factors such as BCLC stage, “Up-to-7” criteria, and Child-Pugh class. Conclusion: HRA may offer comparable long-term efficacy to HR alone in mHCC, suggesting broader treatment options that challenge the guideline-based monotherapy.
- 27 April 2024
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 44 (5) , 2133-2140
Long-term Outcomes of Hepatic Resection Combined With Intraoperative AblationVersusHepatic Resection Alone for Multinodular Hepatocellular Carcinoma: Insights from a Single-center Study
Background/Aim: The efficacy of combining hepatic resection (HR) with ablation therapy in treating multinodular hepatocellular carcinoma (mHCC) remains uncertain. This study aimed to compare the long-term survival outcomes of patients with mHCC undergoing HR combined with intraoperative ablation (HRA) versus those undergoing HR alone. Patients and Methods: A retrospective analysis was conducted on 296 patients diagnosed with early-stage [Barcelona Clinic Liver Cancer (BCLC)-A] or intermediate-stage (BCLC-B) mHCC who underwent initial HR. Patients were divided into two groups: those who received HRA (HRA group, n=159) and those who underwent HR alone (HR group, n=137). Propensity score (PS), estimated as the likelihood of undergoing HRA, was applied to adjust for between-group differences in baseline characteristics. Overall survival (OS) and relapse-free survival (RFS) were compared using Cox regression and Kaplan–Meier analyses. Results: There were no significant differences in survival between the HRA and HR groups, with 5-year OS and RFS rates of 47.7% versus 51.9% (p=0.837) and 17.0% versus 25.9% (p=0.094), respectively. After adjusting for PS, the differences remained non-significant (p=0.579 for OS and p=0.410 for RFS). Consistent results were also observed in PS-adjusted subgroup analysis stratified by factors such as BCLC stage, “Up-to-7” criteria, and Child-Pugh class. Conclusion: HRA may offer comparable long-term efficacy to HR alone in mHCC, suggesting broader treatment options that challenge the guideline-based monotherapy.
- 4 March 2024
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 409 (1) , 1-10
High hand grip strength is a significant risk factor and a useful predictor of postoperative pancreatic fistula following pancreaticoduodenectomy
Background Postoperative pancreatic fistula (POPF) is one of the most critical complications of pancreaticoduodenectomy (PD). Studies on predictive factors for POPF that can be identified preoperatively are limited. Recent reports have highlighted the association between the preoperative nutritional status, including sarcopenia, and postoperative complications. We examined preoperative risk factors for POPF after PD, focusing on nutritional indicators. Methods A total of 153 consecutive patients who underwent PD at our institution were enrolled in this study. Preoperative nutritional parameters, including hand grip strength (HGS) and skeletal muscle mass as components of sarcopenia, were incorporated into the analysis. POPFs were categorized according to the International Study Group of Pancreatic Fistula (ISGPF) definition as biochemical (grade A) or clinically relevant (CR-POPF; grades B and C). Results Thirty-seven of the 153 patients (24.1%) fulfilled the ISGPF definition of CR-POPF postoperatively. In the univariate analysis, the incidence of CR-POPF was associated with male sex, non-pancreatic tumor diseases, a high body mass index, a high HGS and a high skeletal muscle mass index. In the multivariate analysis, non-pancreatic tumor diseases and an HGS ≥23.0 kg were selected as independent risk factors for CR-POPF (P <0.05). Conclusions A high HGS, a screening tool for sarcopenia, was a risk factor for CR-POPF. It can accurately serve as a useful predictor of POPF risk in patients undergoing PD. These results highlight the potential of sarcopenia to reduce the incidence of POPF and highlight the need to clarify the mechanism of POPF occurrence.
- 4 March 2024
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 409 (1) , 1-10
High hand grip strength is a significant risk factor and a useful predictor of postoperative pancreatic fistula following pancreaticoduodenectomy
Background Postoperative pancreatic fistula (POPF) is one of the most critical complications of pancreaticoduodenectomy (PD). Studies on predictive factors for POPF that can be identified preoperatively are limited. Recent reports have highlighted the association between the preoperative nutritional status, including sarcopenia, and postoperative complications. We examined preoperative risk factors for POPF after PD, focusing on nutritional indicators. Methods A total of 153 consecutive patients who underwent PD at our institution were enrolled in this study. Preoperative nutritional parameters, including hand grip strength (HGS) and skeletal muscle mass as components of sarcopenia, were incorporated into the analysis. POPFs were categorized according to the International Study Group of Pancreatic Fistula (ISGPF) definition as biochemical (grade A) or clinically relevant (CR-POPF; grades B and C). Results Thirty-seven of the 153 patients (24.1%) fulfilled the ISGPF definition of CR-POPF postoperatively. In the univariate analysis, the incidence of CR-POPF was associated with male sex, non-pancreatic tumor diseases, a high body mass index, a high HGS and a high skeletal muscle mass index. In the multivariate analysis, non-pancreatic tumor diseases and an HGS ≥23.0 kg were selected as independent risk factors for CR-POPF (P <0.05). Conclusions A high HGS, a screening tool for sarcopenia, was a risk factor for CR-POPF. It can accurately serve as a useful predictor of POPF risk in patients undergoing PD. These results highlight the potential of sarcopenia to reduce the incidence of POPF and highlight the need to clarify the mechanism of POPF occurrence.